Inventor · disambiguated record
Jeffrey Wu
Also filed as: WU JEFFREY · WU JEFFREY C
14 granted patents·2 pending applications·83 citations·filing 2008–2022
90Inventor score
Files withPLEXXIKON INC5NURIX THERAPEUTICS INC3ROCHE PALO ALTO LLC3US GOV VETERANS AFFAIRS2BUNDY BRADLEY C1
Top patents by PatentIndex Score
16 records- 0195US9718847B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2014·Granted Aug 1, 2017·33 cites·21 claims
- 0294US11866442B2Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·5 cites·37 claims
- 0393US11479556B1Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Granted Oct 25, 2022·9 cites·106 claims
- 0492US9938273B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Apr 10, 2018·17 cites·43 claims
- 0588US11976071B2Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinasesNURIX THERAPEUTICS INC·Filed 2022·Granted May 7, 2024·2 cites·14 claims
- 0688US10703757B2Compounds and methods for CDK8 modulation and indications thereforPLEXXIKON INC·Filed 2017·Granted Jul 7, 2020·4 cites·38 claims
- 0787US10160747B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 25, 2018·8 cites·25 claims
- 0884US10519177B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted Dec 31, 2019·4 cites·22 claims
- 0972US11446287B2Compounds and methods for EP300 or CBP modulation and indications thereforOPNA IMMUNO ONCOLOGY SA·Filed 2020·Granted Sep 20, 2022·1 cites·37 claims
- 1067US10857174B2Morpholino oligonucleotides useful in cancer treatmentUS GOV VETERANS AFFAIRS·Filed 2019·Granted Dec 8, 2020·0 cites·18 claims
- 1162US11679121B2Morpholino oligonucleotides useful in cancer treatmentUS GOV VETERANS AFFAIRS·Filed 2020·Granted Jun 20, 2023·0 cites·20 claims
- 1250US8026362B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2008·Granted Sep 27, 2011·0 cites·22 claims
- 1350US7947709B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2008·Granted May 24, 2011·0 cites·11 claims
- 1448US2008293664A1Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2008·Application pending·0 cites
- 1540US2016115487A1Cell-free synthetic incorporation of non-natural amino acids into proteinsBUNDY BRADLEY C·Filed 2014·Application pending·0 cites
- 1639US9981977B2Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalystUNIV CALIFORNIA·Filed 2012·Granted May 29, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →